WEALTHMAKERS.COM Issues Bullish Research Reports on AAV, AOI, CORT …

Published August 8, 2013

WEALTHMAKERS.COM Issues Bullish Research Reports on AAV, AOI, CORT …
The company focuses on commercializing Korlym (mifepristone) 300 mg Tablet, a once-daily oral medication for treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing s syndrome, who have type 2 diabetes … Read more on MENAFN.COM

Findings Presented at ENDO 2013 Support Therapeutic Potential of Natpara …
… levels of active vitamin D in the normal range despite a significant reduction in active vitamin D requirements, while maintaining serum calcium at or near baseline, and reducing 24-hour urinary calcium in patients deficient in endogenous PTH … Read more on Lifescience-online

Shady future Dsh